A Metabolomic Investigation of Eugenol on Colorectal Cancer Cell Line HT-29 by Modifying the Expression of APC, p53, and KRAS Genes

Figure 4

VIP scores of HT-29 cells treated with eugenol and the control group in the (a) hydrophilic phase and (b) lipophilic phase.

(a)

(b)